Technology

‘You Can See Everything’ Passes $100 Million Worldwide

Martin HollowayPublished 3 min readBased on 1 source
Reading level
‘You Can See Everything’ Passes $100 Million Worldwide
Photo by Photo by Max Morse for TechCrunch TechCrunch / CC BY 2.0

You Can See Everything, the documentary about Theranos founder Elizabeth Holmes made by Nathan Fielder and Lance Oppenheim, has grossed $102.4 million worldwide, according to TechCrunch. The figure was reported on November 22, 2026.

U.S. audiences account for $93.4 million of that total, leaving roughly $9 million from the rest of the world. That split gives an early read on how far the film has travelled beyond its home market.

The film carried a reported budget of $7 million. Measured against that figure, worldwide gross comes to about 14.6 times production cost. Gross here means total ticket receipts before any share goes to cinemas or distributors.

The international rollout is next. The film opens in Mexico, Brazil and Argentina on November 25 and 26, three days after the reporting date, and will open in many more countries over the next few months. The first markets are all in Latin America, which puts Spanish- and Portuguese-language audiences at the front of the international run.

In my view, the staggered release will matter more to the film's trajectory than the current headline number. Each market that opens adds receipts, so the $102.4 million figure is a checkpoint rather than a final tally. Even so, the gap between cost and gross is wide enough to make the release pattern a more revealing story than the total itself.

For readers who follow health technology and corporate governance, the subject needs little introduction. Theranos is a well-documented corporate failure, so much of the audience arrives with context already in hand. That familiarity may shape how quickly the film finds viewers in each new market.

The film is now a practical test of whether a documentary about a technology company's failures can travel across borders on a modest budget. The international run is still ahead, so the current total is a starting point rather than a verdict on the film's reach.